Dr. Carlo Castruccio Castracani
Carlo graduated from the Pharmacy School in 2016 and he obtained a PhD in Neurosciences in 2019 at the University of Catania (Italy). His PhD thesis focuses the attention on the role of Heme Oxygenase-1 in brain cancers, especially in glioblastoma. He also spent one year at Temple University, hosted by the College of Science and Technology, to improve his skills using the CRISPR-Cas9 technology and the Zebrafish (Danio rerio) animal model. He joined the Rivella Lab in March 2020 as Research Post-Doctoral Fellow. Using a combination of in vivo and in vitro experiments, Carlo is working on new gene therapy strategies for the Congenital Sideroblastic Anemia, occurring when the bone marrow fails to produce a sufficient number of healthy red blood cells.